T1	Participants 1 87	Treating rheumatoid arthritis patients of Shen deficiency and cold invading syndrome b
T2	Participants 423 647	RA patients of Shen deficiency and cold invading syndrome in the treatment group (120 cases) were treated with BQZD and MTX (10 mg/week), while those in the control group (120 cases) were treated with MTX (10 mg/week) alone.
